Health Secretary Wes Streeting expressed gratitude for the opportunity to meet with former Little Mix member Jesy Nelson and commended her bravery in sharing her personal story. Nelson met with Streeting to advocate for newborn screening for spinal muscular atrophy (SMA) after her twin babies were diagnosed with the condition, which will likely impact their ability to walk.
The Mirror is actively campaigning for the inclusion of a simple £5 SMA screening test in the NHS newborn heel prick test to enable early treatment and potential cure before irreversible nerve damage occurs. Streeting acknowledged Nelson’s compelling case for enhanced screening efforts and highlighted progress in this area, including a large-scale study recommended by the UK National Screening Committee and upcoming trials to screen hundreds of thousands of babies for SMA.
The meeting with Streeting, which was attended by SMA UK, emphasized the critical importance of timely diagnoses to prevent severe consequences. The discussion was recorded and is set to be featured on ITV’s This Morning. Streeting emphasized the need for improved screening processes and utilization of genomic medicine to address delays in diagnosis.
Pharmaceutical company Novartis estimated that 33 UK babies annually become wheelchair-bound due to late SMA diagnosis. Zolgensma, a gene therapy available on the NHS since 2021, offers a one-time treatment that can preserve essential functions in babies with SMA if administered promptly after birth. Novartis UK’s Chief Medical Officer urged the government to expand newborn screening for SMA to align with European standards.
Late diagnosis of SMA, particularly Type 1, often leads to significant health challenges and reliance on medical support. Jesy Nelson, a first-time mother, shared her emotional journey and frustration with delayed diagnosis, emphasizing the urgency of early intervention to prevent irreversible muscle deterioration in infants.
By raising awareness and advocating for improved screening practices, Nelson and stakeholders aim to ensure that infants with SMA receive prompt and effective treatment to enhance their quality of life.
